PHIIDO - disease progression

This trial is enrolling now. Depending on eligibility and available places in your area, you may be able to enrol in this trial.

About this trial

The purpose of this study  is to investigate the natural history of HIV from seroconversion and see how it affects the immune system. A group of people newly infected with HIV will  be followed for two years.

There will be no interventions but participants' viral loads and CD4 counts will be assessed every three months .

Official title:

A prospective cohort study of individuals with primary Human Immunodefiency Virus (HIV) infection to determine immunological and virological factors related to disease progression.

What is this trial studying?

other

Start date:

2009 (This may be the proposed or expected start date for trials which have not yet started.)

How many participants will this trial enrol?

20 (The exact number of participants may be lower or slightly higher than this. Some trials also have specific quotas for participants from each state, city or clinic.)

How long is this trial planned to go for?

Participants in this trial will be asked to follow the trial protocol for 2 years.

Links to further information:

• http://www.anzctr.org.au/trial_view.aspx?ID=83939

Who can enrol in this trial?

You may be eligible to participate in this trial if you meet the following criteria:

• At least 18 years old
• Have never taken HIV treatments
• Recently been infected with HIV, or undergoing seroconversion

This is a summary of key inclusion and exclusion criteria for this trial. There may be other criteria which may exclude some people from participation in this trial. Some laboratory tests may also be required. Consult your doctor, or view the trial protocol or informed consent documentation to see the full range of exclusion and inclusion criteria.

If you are interested in enrolling in this trial

Before making the decision to participate in any clinical trial, NAPWA recommends that you discuss the potential benefits and risks of participation with your treating doctor. Your doctor can also provide advice about your eligibility to participate in the trial.

While NAPWA has taken every care to compile the information on this page and to keep it up-to-date, we cannot guarantee its correctness and completeness.

Before making the decision to participate in any clinical research, visit the NAPWA website for background information on participating in clinical research.

Contact NAPWA if you have any questions or comments about this trial.